Godrej Agrovet's Q3 FY26: Strong Performance Driven by Margin Expansion and Strategic Shifts

Godrej Agrovet Limited has reported a robust performance for the third quarter of fiscal year 2026, showcasing significant growth across its key business segments. The company's consolidated revenues climbed by a healthy 11% year-on-year, reaching ₹2,718 crore. This growth was accompanied by an even sharper acceleration in profitability, with Profit Before Tax (PBT), excluding non-recurring and exceptional items, surging by 23% year-on-year to ₹169 crore. The strong results underscore the effectiveness of disciplined margin expansion, operational efficiencies, and strategic contributions from its diverse portfolio, notably Animal Feed, Vegetable Oil, Poultry, Processed Foods, and a remarkable turnaround in Astec LifeSciences.

For the nine-month period ending December 31, 2025, Godrej Agrovet posted consolidated revenues of ₹7,900 crore, marking a 9% increase over the previous year. PBT for the same period, excluding non-recurring and exceptional items, stood at ₹482 crore, reflecting a healthy 17% year-on-year growth. The company's strategic focus on value-added products and operational excellence has been a key driver, allowing it to navigate challenging market conditions in certain segments while capitalizing on growth opportunities in others.

Segmental Performance Highlights

The Animal Feed segment delivered another quarter of strong volume-led growth, with volumes increasing by 12% year-on-year in Q3 FY26. Cattle feed volumes, in particular, saw a significant 21% year-on-year rise, contributing substantially to the overall expansion. The underlying segment results improved by 17% year-on-year, with the underlying EBIT per metric ton reaching ₹2,020 in Q3 FY26. This growth was supported by new product launches like 'Dhanalaxmi G' in Western India and 'Bypro Plus' in Southern India, which have received positive market responses.

The Vegetable Oil business continued its stellar performance, with segment revenue growing 27% year-on-year in Q3 FY26. This was primarily driven by higher volumes of end-products, supported by a 16% improvement in Fresh Fruit Bunch (FFB) arrivals and an improved Oil Extraction Ratio (OER) of 21%. The company is also expanding its capabilities with a new CPO processing plant in Khammam expected to go live in two months and a downstream refinery commissioned in Q1 of the next fiscal year, aiming to enhance its value-added product portfolio.

Astec LifeSciences registered a strong recovery, with revenues growing 33% year-on-year in Q3 FY26. The segment turned EBITDA positive at ₹5 crore, a significant improvement from a loss in the same period last year. This turnaround was supported by robust volume growth across both enterprise and CDMO categories, along with improved gross margins. The company has also secured new product registrations for Cyproconazole and Tebuconazole in Brazil and European equivalence for Metconazole, unlocking new growth markets.

Conversely, the Creamline Dairy business was impacted by higher milk procurement prices and a revenue shortfall, leading to a 38% decline in EBITDA to ₹11 crore in Q3 FY26. The Crop Protection business also faced challenges, with segment margins remaining flat due to lower volumes in in-licensing and in-house categories, severely affected by unseasonal rains and cyclones in key geographies. Despite these headwinds, the company is diversifying its product portfolio with new launches like 'Ashitaka' (maize herbicide) and 'Takai' (paddy insecticide).

Financial Summary (Consolidated)

*PBT before profit of share of associates & excluding non-recurring & exceptional items

Strategic Direction and Outlook

Godrej Agrovet is actively pursuing a strategy of portfolio optimization and value creation. Management indicated that a deep strategic review is nearing completion, which will lead to clear choices regarding investments and growth priorities. The focus is on playing in attractive markets with a strong right to win, ensuring significant capital allocation to prioritized businesses. This includes a continued shift towards value-added branded products in the Foods business, with branded salience rising to 81% in Q3 FY26 from 77% last year. The company aims for its branded retail business, particularly 'Yummiez', to continue increasing its share over the next five years, ultimately becoming a pure-play branded retail organization.

In the Vegetable Oil segment, the company anticipates FFB tonnage growth of 12-15% CAGR over the long term, supported by acreage expansion and farmer engagement programs. For Astec LifeSciences, the guidance includes achieving EBITDA breakeven for FY26 and targeting a 15% revenue growth for FY27, driven by robust volume growth in both enterprise and CDMO categories and new market registrations.

Commitment to Sustainability

Godrej Agrovet continues to demonstrate strong leadership in environmental, social, and governance (ESG) initiatives. The company's renewable energy portfolio stands at 78.9%, and it is 14x water positive, having sequestered 22.14 million m³ of water against a consumption of 1.58 million m³. It holds an 'A-' leadership band in CDP Climate & Forest (Palm) and a 'Gold' rating from EcoVadis for sustainability. As the first Agri company in India to have approved science-based emission reduction targets, Godrej Agrovet is committed to a 37.5% reduction in Scope 1 & 2 GHG emissions by FY35 from a FY20 baseline. These commitments reinforce the company's dedication to responsible and future-ready growth.

Godrej Agrovet's Q3 FY26 performance reflects a company that is strategically adapting to market dynamics, investing in growth areas, and committed to sustainability. Despite facing headwinds in certain segments, the overall trajectory is positive, driven by strong operational execution and a clear vision for value-added growth across its diverse agricultural portfolio. The management's focus on margin expansion, new product development, and market diversification positions the company for sustained performance in the coming years.